Last edition
News about "Crick Research"
Slingshot Backs New Precision Oncology Venture from Crick Research
Slingshot Therapeutics, Syncona’s accelerator platform for advancing early-stage drug discovery programmes, has launched ALTx Therapeutics with an initial £12.55 million funding commitment from Syncona, the Francis Crick Institute, and Cancer Research Horizons.
Crick Research | 07/02/2026 | By Darshana | 140
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members